Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Julie-An M. Talano MD

Julie-An M. Talano MD profile photo picture

Professor

Institution: Medical College of Wisconsin
Department: Pediatrics
Division: Hematology and Oncology - Pediatrics
Program: Oncology

Member of the Cancer Center
Member of the Center for Immunology

View Curriculum Vitae

Research Experience

  • Bone Marrow Transplantation
  • Hematopoietic Stem Cell Transplantation
  • Lymphohistiocytosis, Hemophagocytic
  • CART cell therapy

    • Clinical Expertise

  • Bone Marrow Transplantation
  • Hematopoietic Stem Cell Transplantation
  • Lymphohistiocytosis, Hemophagocytic
  • Mesenchymal Stem Cell Transplantation
  • Stem Cell Transplantation
  • T-Lymphocytes
  • Transplantation Conditioning
  • CART cell therapy

    • Publications (84)

  • Hemophagocytic Lymphohistiocytosis in Adolescents and Young Adults: Genetic Predisposition and Secondary Disease (Vasco AE, Talano JA, Broglie L) Medical Clinics of North America January 2024;108(1):189-200 SCOPUS ID: 2-s2.0-85164721337 01/01/2024    
  • Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation. (Böhm S, Wustrau K, Pachlopnik Schmid J, Prader S, Ahlmann M, Yacobovich J, Beier R, Speckmann C, Behnisch W, Ifversen M, Jordan M, Marsh R, Naumann-Bartsch N, Mauz-Körholz C, Hönig M, Schulz A, Malinowska I, Hines M, Nichols KE, Gil-Herrera J, Talano JA, Crooks B, Formankova R, Jorch N, Bakhtiar S, Kühnle I, Streiter M, Nathrath M, Russo A, Dürken M, Lang P, Lindemans C, Henter JI, Lehmberg K, Ehl S) Blood 2024 Mar 07;143(10):872-881 PMID: 37992218 SCOPUS ID: 2-s2.0-85184047930 11/22/2023       2 Citations
  • Mediport use as an acceptable standard for CAR T cell infusion. (Eylon M, Prabhu S, John S, King MJM, Bhatt D, Curran KJ, Erickson C, Karras NA, Phillips CL, Satwani P, Hermiston M, Southworth E, Baumeister SHC, Talano JA, MacMillan ML, Rossoff J, Bonifant CL, Myers GD, Rouce RH, Toner K, Driscoll TA, Katsanis E, Salzberg DB, Schiff D, De Oliveira SN, Capitini CM, Pacenta HL, Pfeiffer T, Shah NC, Huynh V, Skiles JL, Fraint E, McNerney KO, Quigg TC, Krueger J, Ligon JA, Fabrizio VA, Baggott C, Laetsch TW, Schultz LM) Front Immunol 2023;14:1239132 PMID: 37965315 PMCID: PMC10642031 SCOPUS ID: 2-s2.0-85176414500 11/15/2023    
  • Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns. (Barsan V, Li Y, Prabhu S, Baggott C, Nguyen K, Pacenta H, Phillips CL, Rossoff J, Stefanski H, Talano JA, Moskop A, Baumeister S, Verneris MR, Myers GD, Karras NA, Cooper S, Qayed M, Hermiston M, Satwani P, Krupski C, Keating A, Fabrizio V, Chinnabhandar V, Kunicki M, Curran KJ, Mackall CL, Laetsch TW, Schultz LM) EClinicalMedicine 2023 Nov;65:102268 PMID: 37954907 PMCID: PMC10632672 SCOPUS ID: 2-s2.0-85174830159 11/13/2023       1 Citation
  • Hemophagocytic Lymphohistiocytosis in Adolescents and Young Adults: Genetic Predisposition and Secondary Disease. (Vasco AE, Talano JA, Broglie L) Med Clin North Am 2024 Jan;108(1):189-200 PMID: 37951650 SCOPUS ID: 2-s2.0-85164721337 11/12/2023    
  • Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns (Barsan V, Li Y, Prabhu S, Baggott C, Nguyen K, Pacenta H, Phillips CL, Rossoff J, Stefanski H, Talano JA, Moskop A, Baumeister S, Verneris MR, Myers GD, Karras NA, Cooper S, Qayed M, Hermiston M, Satwani P, Krupski C, Keating A, Fabrizio V, Chinnabhandar V, Kunicki M, Curran KJ, Mackall CL, Laetsch TW, Schultz LM) eClinicalMedicine November 2023;65 SCOPUS ID: 2-s2.0-85174830159 11/01/2023       1 Citation
  • Practice Preferences for Consolidative Hematopoietic Stem Cell Transplantation Following Tisagenlecleucel in Children and Young Adults with B Cell Acute Lymphoblastic Leukemia. (McNerney KO, Moskop A, Winestone LE, Baggott C, Talano JA, Schiff D, Rossoff J, Modi A, Verneris MR, Laetsch TW, Schultz L) Transplant Cell Ther 2024 Jan;30(1):75.e1-75.e11 PMID: 37816472 SCOPUS ID: 2-s2.0-85176374452 10/11/2023    
  • Haplo ever after: haplo PTCy for children. (Talano JA, Broglie L) Blood Adv 2023 Sep 26;7(18):5637-5638 PMID: 37756536 PMCID: PMC10546334 SCOPUS ID: 2-s2.0-85173517292 09/27/2023    
  • No impact of CD34+ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma. (Knight TE, Ahn KW, Hebert KM, Atshan R, Wall DA, Chiengthong K, Lund TC, Prestidge T, Rangarajan HG, Dvorak CC, Auletta JJ, Kent M, Hashem H, Talano JA, Rotz SJ, Fraint E, Myers KC, Leung W, Sharma A, Bhatt NS, Driscoll TA, Yu LC, Schultz KR, Qayed M, Broglie L, Eapen M, Yanik GA) Bone Marrow Transplant 2023 Dec;58(12):1390-1393 PMID: 37666957 SCOPUS ID: 2-s2.0-85169665242 09/05/2023    
  • The impacts of total body irradiation on umbilical cord blood hematopoietic stem cell transplantation. (Wang H, Berger KN, Miller EL, Fu W, Broglie L, Goldman FD, Konig H, Lim SJ, Berg AS, Talano JA, Comito MA, Farag SS, Pu JJ) Ther Adv Hematol 2023;14:20406207231170708 PMID: 37151808 PMCID: PMC10161310 SCOPUS ID: 2-s2.0-85158064897 05/08/2023    
  • Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT. (Geerlinks AV, Scull B, Krupski C, Fleischmann R, Pulsipher MA, Eapen M, Connelly JA, Bollard CM, Pai SY, Duncan CN, Kean LS, Baker KS, Burroughs LM, Andolina JR, Shenoy S, Roehrs P, Hanna R, Talano JA, Schultz KR, Stenger EO, Lin H, Zoref-Lorenz A, McClain KL, Jordan MB, Man TK, Allen CE, Marsh RA) Blood Adv 2023 Jul 25;7(14):3725-3734 PMID: 37042921 PMCID: PMC10368780 SCOPUS ID: 2-s2.0-85183633571 04/13/2023    
  • HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL. (McNerney KO, Si Lim SJ, Ishikawa K, Dreyzin A, Vatsayan A, Chen JJ, Baggott C, Prabhu S, Pacenta HL, Philips C, Rossoff J, Stefanski HE, Talano JA, Moskop A, Verneris M, Myers D, Karras NA, Brown P, Bonifant CL, Qayed M, Hermiston M, Satwani P, Krupski C, Keating AK, Baumeister SHC, Fabrizio VA, Chinnabhandar V, Egeler E, Mavroukakis S, Curran KJ, Mackall CL, Laetsch TW, Schultz LM) Blood Adv 2023 Jun 27;7(12):2758-2771 PMID: 36857419 PMCID: PMC10275701 SCOPUS ID: 2-s2.0-85164935646 03/02/2023       1 Citation
  • GATA2 deficiency detected by newborn screening for SCID: A case report. (Escobar Vasco A, Broglie L, Talano JA, Routes J, Verbsky J, Remiker A) Front Pediatr 2022;10:1031106 PMID: 36726998 PMCID: PMC9886089 SCOPUS ID: 2-s2.0-85147166600 02/03/2023    
  • SARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry report. (McNerney KO, Richards RM, Aguayo-Hiraldo P, Calkoen FG, Talano JA, Moskop A, Balduzzi A, Krajewski J, Dave H, Vatsayan A, Callahan C, Liu H, Li Y, Davis KL, Maude SL) J Immunother Cancer 2023 Jan;11(1) PMID: 36707090 PMCID: PMC9884906 SCOPUS ID: 2-s2.0-85147092151 01/28/2023       5 Citations
  • Manufacture and Characterization of Good Manufacturing Practice-Compliant SARS-COV-2 Cytotoxic T Lymphocytes. (Chu Y, Milner J, Lamb M, Maryamchik E, Rigot O, Ayello J, Harrison L, Shaw R, Behbehani GK, Mardis ER, Miller K, Prakruthi Rao Venkata L, Chang H, Lee D, Rosenthal E, Kadauke S, Bunin N, Talano JA, Johnson B, Wang Y, Cairo MS) J Infect Dis 2023 Mar 28;227(6):788-799 PMID: 36583990 SCOPUS ID: 2-s2.0-85151044080 12/31/2022    
  • Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell disease. (Chu Y, Talano JA, Baxter-Lowe LA, Verbsky JW, Morris E, Mahanti H, Ayello J, Keever-Taylor C, Johnson B, Weinberg RS, Shi Q, Moore TB, Fabricatore S, Grossman B, van de Ven C, Shenoy S, Cairo MS) Front Immunol 2022;13:1055497 PMID: 36569951 PMCID: PMC9780682 SCOPUS ID: 2-s2.0-85144637382 12/27/2022    
  • Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia. (Schultz LM, Eaton A, Baggott C, Rossoff J, Prabhu S, Keating AK, Krupski C, Pacenta H, Philips CL, Talano JA, Moskop A, Baumeister SHC, Myers GD, Karras NA, Brown PA, Qayed M, Hermiston M, Satwani P, Wilcox R, Rabik CA, Fabrizio VA, Chinnabhandar V, Kunicki M, Mavroukakis S, Egeler E, Li Y, Mackall CL, Curran KJ, Verneris MR, Laetsch TW, Stefanski H) J Clin Oncol 2023 Jan 10;41(2):354-363 PMID: 36108252 PMCID: PMC9839307 SCOPUS ID: 2-s2.0-85145668660 09/16/2022       25 Citations
  • Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium. (Stefanski HE, Eaton A, Baggott C, Rossoff J, Verneris MR, Prabhu S, Pacenta HL, Phillips CL, Talano JA, Moskop A, Margossian SP, Myers GD, Karras NA, Brown PA, Qayed M, Hermiston M, Satwani P, Krupski MC, Keating AK, Wilcox R, Rabik CA, Fabrizio VA, Chinnabhandar V, Goksenin AY, Curran KJ, Mackall CL, Laetsch TW, Schultz LM) Blood Adv 2023 Feb 28;7(4):541-548 PMID: 35938863 PMCID: PMC9979765 SCOPUS ID: 2-s2.0-85139688392 08/09/2022       24 Citations
  • Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial. (DeZern AE, Eapen M, Wu J, Talano JA, Solh M, Dávila Saldaña BJ, Karanes C, Horwitz ME, Mallhi K, Arai S, Farhadfar N, Hexner E, Westervelt P, Antin JH, Deeg HJ, Leifer E, Brodsky RA, Logan BR, Horowitz MM, Jones RJ, Pulsipher MA) Lancet Haematol 2022 Sep;9(9):e660-e669 PMID: 35907408 PMCID: PMC9444987 SCOPUS ID: 2-s2.0-85135889621 07/31/2022       22 Citations
  • KIR-favorable TCR-αβ/CD19-depleted haploidentical HCT in children with ALL/AML/MDS: primary analysis of the PTCTC ONC1401 trial. (Pulsipher MA, Ahn KW, Bunin NJ, Lalefar N, Anderson E, Flower A, Cairo MS, Talano JA, Chaudhury S, Kitko CL, Duke JL, Monos D, Leung W, Dvorak CC, Abdel-Azim H) Blood 2022 Dec 15;140(24):2556-2572 PMID: 35776909 PMCID: PMC9918850 SCOPUS ID: 2-s2.0-85144585749 07/02/2022       10 Citations
  • Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia. (Moskop A, Pommert L, Baggott C, Prabhu S, Pacenta HL, Phillips CL, Rossoff J, Stefanski HE, Talano JA, Margossian SP, Verneris MR, Myers GD, Karras NA, Brown PA, Qayed M, Hermiston ML, Satwani P, Krupski C, Keating AK, Wilcox R, Rabik CA, Fabrizio VA, Chinnabhandar V, Goksenin AY, Curran KJ, Mackall CL, Laetsch TW, Guest EM, Breese EH, Schultz LM) Blood Adv 2022 Jul 26;6(14):4251-4255 PMID: 35580324 PMCID: PMC9327536 SCOPUS ID: 2-s2.0-85134824972 05/18/2022       19 Citations
  • Pediatric Donor Cell Acute Lymphoblastic Leukemia Following Bone Marrow Transplant for GATA2 Mutation. (Scheuermann A, Moskop A, Hopp A, Bone K, Drendel HM, Talano J, Harker-Murray P, Astle J) J Pediatr Hematol Oncol 2022 Jul 01;44(5):268-270 PMID: 35235548 SCOPUS ID: 2-s2.0-85129146818 03/03/2022       3 Citations
  • Significant improvement of child physical and emotional functioning after familial haploidentical stem cell transplant. (Parsons SK, Rodday AM, Weidner RA, Morris E, Braniecki S, Shenoy S, Talano JA, Moore TB, Panarella A, Flower A, Milner J, Fabricatore S, Mahanti H, van de Ven C, Shi Q, Cairo MS) Bone Marrow Transplant 2022 Apr;57(4):586-592 PMID: 35110690 SCOPUS ID: 2-s2.0-85124075038 02/04/2022       2 Citations
  • Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report. (Schultz LM, Baggott C, Prabhu S, Pacenta HL, Phillips CL, Rossoff J, Stefanski HE, Talano JA, Moskop A, Margossian SP, Verneris MR, Myers GD, Karras NA, Brown PA, Qayed M, Hermiston M, Satwani P, Krupski C, Keating AK, Wilcox R, Rabik CA, Fabrizio VA, Rouce RH, Chinnabhandar V, Kunicki M, Barsan VV, Goksenin AY, Li Y, Mavroukakis S, Egeler E, Curran KJ, Mackall CL, Laetsch TW) J Clin Oncol 2022 Mar 20;40(9):945-955 PMID: 34882493 PMCID: PMC9384925 SCOPUS ID: 2-s2.0-85126005350 12/10/2021       79 Citations
  • Unrelated donor α/β T cell- and B cell-depleted HSCT for the treatment of pediatric acute leukemia. (Leahy AB, Li Y, Talano JA, Elgarten CW, Seif AE, Wang Y, Johnson B, Monos DS, Kadauke S, Olson TS, Freedman J, Wray L, Grupp SA, Bunin N) Blood Adv 2022 Feb 22;6(4):1175-1185 PMID: 34872106 PMCID: PMC8864664 SCOPUS ID: 2-s2.0-85125302478 12/07/2021       7 Citations
  • Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report. (Fabrizio VA, Phillips CL, Lane A, Baggott C, Prabhu S, Egeler E, Mavroukakis S, Pacenta H, Rossoff J, Stefanski HE, Talano JA, Moskop A, Margossian SP, Verneris MR, Myers GD, Karras NA, Brown PA, Qayed M, Hermiston M, Satwani P, Krupski C, Keating AK, Wilcox R, Rabik CA, Chinnabhandar V, Kunicki M, Goksenin AY, Curran KJ, Mackall CL, Laetsch TW, Schultz LM) Blood Adv 2022 Jan 25;6(2):600-610 PMID: 34794180 PMCID: PMC8791593 SCOPUS ID: 2-s2.0-85123516789 11/19/2021       31 Citations
  • Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy. (Fabrizio VA, Boelens JJ, Mauguen A, Baggott C, Prabhu S, Egeler E, Mavroukakis S, Pacenta H, Phillips CL, Rossoff J, Stefanski HE, Talano JA, Moskop A, Margossian SP, Verneris MR, Myers GD, Karras NA, Brown PA, Qayed M, Hermiston M, Satwani P, Krupski C, Keating AK, Wilcox R, Rabik CA, Chinnabhandar V, Kunicki M, Goksenin AY, Mackall CL, Laetsch TW, Schultz LM, Curran KJ) Blood Adv 2022 Apr 12;6(7):1961-1968 PMID: 34788386 PMCID: PMC9006295 SCOPUS ID: 2-s2.0-85128537799 11/18/2021       45 Citations
  • Out-of-specification tisagenlecleucel does not compromise safety or efficacy in pediatric acute lymphoblastic leukemia. (Rossoff J, Baggott C, Prabhu S, Pacenta H, Phillips CL, Stefanski H, Talano JA, Moskop A, Margossian SP, Verneris MR, Myers GD, Karras N, Brown PA, Qayed M, Hermiston M, Satwani P, Krupski C, Keating AK, Wilcox R, Rabik CA, Fabrizio VA, Kunicki M, Chinnabhandar V, Goksenin AY, Curran KJ, Mackall CL, Laetsch TW, Schultz LM) Blood 2021 Nov 25;138(21):2138-2142 PMID: 34499715 PMCID: PMC8617436 SCOPUS ID: 2-s2.0-85119700502 09/10/2021       4 Citations
  • Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy. (Kharfan-Dabaja MA, Kumar A, Ayala E, Aljurf M, Nishihori T, Marsh R, Burroughs LM, Majhail N, Al-Homsi AS, Al-Kadhimi ZS, Bar M, Bertaina A, Boelens JJ, Champlin R, Chaudhury S, DeFilipp Z, Dholaria B, El-Jawahri A, Fanning S, Fraint E, Gergis U, Giralt S, Hamilton BK, Hashmi SK, Horn B, Inamoto Y, Jacobsohn DA, Jain T, Johnston L, Kanate AS, Kansagra A, Kassim A, Kean LS, Kitko CL, Knight-Perry J, Kurtzberg J, Liu H, MacMillan ML, Mahmoudjafari Z, Mielcarek M, Mohty M, Nagler A, Nemecek E, Olson TS, Oran B, Perales MA, Prockop SE, Pulsipher MA, Pusic I, Riches ML, Rodriguez C, Romee R, Rondon G, Saad A, Shah N, Shaw PJ, Shenoy S, Sierra J, Talano J, Verneris MR, Veys P, Wagner JE, Savani BN, Hamadani M, Carpenter PA) Transplant Cell Ther 2021 Aug;27(8):642-649 PMID: 34304802 SCOPUS ID: 2-s2.0-85111026486 07/27/2021       67 Citations
  • Stable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantation. (Friedman D, Dozor AJ, Milner J, D'Souza M, Talano JA, Moore TB, Shenoy S, Shi Q, Walters MC, Vichinsky E, Parsons SK, Braniecki S, Moorthy CR, Ayello J, Flower A, Morris E, Mahanti H, Fabricatore S, Klejmont L, van de Ven C, Baxter-Lowe LA, Cairo MS) Bone Marrow Transplant 2021 Sep;56(9):2221-2230 PMID: 33958740 PMCID: PMC8416746 SCOPUS ID: 2-s2.0-85111544082 05/08/2021       11 Citations
  • Chimeric antigen receptor T-cell therapy for marrow and extramedullary relapse of infant acute lymphoblastic leukemia. (Moskop A, Pommert L, Thakrar P, Talano J, Phelan R) Pediatr Blood Cancer 2021 Jan;68(1):e28739 PMID: 33009894 SCOPUS ID: 2-s2.0-85091860342 10/04/2020       7 Citations
  • Neuroinflammatory Disease as an Isolated Manifestation of Hemophagocytic Lymphohistiocytosis. (Blincoe A, Heeg M, Campbell PK, Hines M, Khojah A, Klein-Gitelman M, Talano JA, Speckmann C, Touzot F, Lankester A, Legger GE, Rivière JG, Garcia-Prat M, Alonso L, Putti MC, Lehmberg K, Maier S, El Chazli Y, Elmaksoud MA, Astigarraga I, Kurjane N, Bulina I, Kenina V, Bryceson Y, Rascon J, Lortie A, Goldstein G, Booth C, Worth A, Wassmer E, Schmitt EG, Warren JT, Bednarski JJ, Ali S, Chiang KY, Krueger J, Henry MM, Holland SM, Marsh RA, Ehl S, Haddad E) J Clin Immunol 2020 Aug;40(6):901-916 PMID: 32638196 SCOPUS ID: 2-s2.0-85087567833 07/09/2020       26 Citations
  • Priorities for Improving Outcomes for Nonmalignant Blood Diseases: A Report from the Blood and Marrow Transplant Clinical Trials Network. (Levine JE, Antin JH, Allen CE, Burroughs LM, Cooke KR, Devine S, Heslop H, Nakamura R, Talano JA, Yanik G, DiFronzo N) Biol Blood Marrow Transplant 2020 May;26(5):e94-e100 PMID: 32035274 PMCID: PMC8062984 SCOPUS ID: 2-s2.0-85081220914 02/09/2020       3 Citations
  • Familial Haploidentical Stem Cell Transplant in Children and Adolescents With High-Risk Sickle Cell Disease: A Phase 2 Clinical Trial. (Cairo MS, Talano JA, Moore TB, Shi Q, Weinberg RS, Grossman B, Shenoy S) JAMA Pediatr 2020 Feb 01;174(2):195-197 PMID: 31816036 PMCID: PMC6902105 SCOPUS ID: 2-s2.0-85076336992 12/10/2019       22 Citations
  • Partially CD3+-Depleted Unrelated and Haploidentical Donor Peripheral Stem Cell Transplantation Has Favorable Graft-versus-Host Disease and Survival Rates in Pediatric Hematologic Malignancy. (Seif AE, Li Y, Monos DS, Heidemann SC, Aplenc R, Barrett DM, Casper JT, Freedman JL, Grupp SA, Margolis DA, Olson TS, Teachey DT, Keever-Taylor CA, Wang Y, Talano JM, Bunin NJ) Biol Blood Marrow Transplant 2020 Mar;26(3):493-501 PMID: 31765697 SCOPUS ID: 2-s2.0-85077542518 11/26/2019       3 Citations
  • Hemophagocytic lymphohistiocytosis mimicking neonatal hemochromatosis. (Broglie L, Vitola B, Thakar MS, Basel D, Szabo S, Agni R, Talano JA) Pediatr Hematol Oncol 2019 Oct;36(7):451-456 PMID: 31424295 PMCID: PMC10099790 SCOPUS ID: 2-s2.0-85071390624 08/20/2019       4 Citations
  • Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient: An Evidence-Based Guide (Duncan CN, Talano JAM, McArthur JA) Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient: An Evidence-Based Guide 1 January 2019:1-417 SCOPUS ID: 2-s2.0-85116797108 01/01/2019       5 Citations
  • Diagnosis, Treatment, and Management of Hemophagocytic Lymphohistiocytosis in the Critical Care Unit (Hines M, Bhatt N, Talano JAM) Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient: An Evidence-Based Guide 1 January 2019:159-182 SCOPUS ID: 2-s2.0-85086380481 01/01/2019       5 Citations
  • First report that prior ECMO therapy does not preclude hematopoietic cell transplantation. (Broglie L, Phelan R, Talano JA) Pediatr Hematol Oncol 2018 May;35(4):245-249 PMID: 30570427 SCOPUS ID: 2-s2.0-85059008833 12/21/2018    
  • Post-transplantation employment status of adult survivors of childhood allogeneic hematopoietic cell transplant: A report from the Center for International Blood and Marrow Transplant Research (CIBMTR). (Bhatt NS, Brazauskas R, Tecca HR, Carreras J, Burns LJ, Phelan R, Salit RB, Syrjala KL, Talano JM, Shaw BE) Cancer 2019 Jan 01;125(1):144-152 PMID: 30368771 PMCID: PMC6310211 SCOPUS ID: 2-s2.0-85055708918 10/29/2018       18 Citations
  • Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies. (Allen CE, Marsh R, Dawson P, Bollard CM, Shenoy S, Roehrs P, Hanna R, Burroughs L, Kean L, Talano JA, Schultz KR, Pai SY, Baker KS, Andolina JR, Stenger EO, Connelly J, Ramirez A, Bryant C, Eapen M, Pulsipher MA) Blood 2018 Sep 27;132(13):1438-1451 PMID: 29997222 PMCID: PMC6161764 SCOPUS ID: 2-s2.0-85053908983 07/13/2018       75 Citations
  • Hemophagocytic lymphohistiocytosis in adults. (Bhatt NS, Oshrine B, An Talano J) Leuk Lymphoma 2019 Jan;60(1):19-28 PMID: 29966474 SCOPUS ID: 2-s2.0-85061376634 07/04/2018       24 Citations
  • Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression. (Jacobsohn DA, Loken MR, Fei M, Adams A, Brodersen LE, Logan BR, Ahn KW, Shaw BE, Kletzel M, Olszewski M, Khan S, Meshinchi S, Keating A, Harris A, Teira P, Duerst RE, Margossian SP, Martin PL, Petrovic A, Dvorak CC, Nemecek ER, Boyer MW, Chen AR, Davis JH, Shenoy S, Savasan S, Hudspeth MP, Adams RH, Lewis VA, Kheradpour A, Kasow KA, Gillio AP, Haight AE, Bhatia M, Bambach BJ, Haines HL, Quigg TC, Greiner RJ, Talano JM, Delgado DC, Cheerva A, Gowda M, Ahuja S, Ozkaynak M, Mitchell D, Schultz KR, Fry TJ, Loeb DM, Pulsipher MA) Biol Blood Marrow Transplant 2018 Oct;24(10):2040-2046 PMID: 29933069 PMCID: PMC6239928 SCOPUS ID: 2-s2.0-85050818070 06/23/2018       30 Citations
  • The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leukemia. (Hochberg J, Zahler S, Geyer MB, Chen N, Krajewski J, Harrison L, Militano O, Ozkaynak MF, Cheerva AC, Talano J, Moore TB, Gillio AP, Walters MC, Baxter-Lowe LA, Hamby C, Cairo MS) Bone Marrow Transplant 2019 Feb;54(2):226-235 PMID: 29899571 SCOPUS ID: 2-s2.0-85048460040 06/15/2018       6 Citations
  • Treosulfan, Fludarabine, and Low-Dose Total Body Irradiation for Children and Young Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation: Prospective Phase II Trial of the Pediatric Blood and Marrow Transplant Consortium. (Nemecek ER, Hilger RA, Adams A, Shaw BE, Kiefer D, Le-Rademacher J, Levine JE, Yanik G, Leung W, Talano JA, Haut P, Delgado D, Kapoor N, Petrovic A, Adams R, Hanna R, Rangarajan H, Dalal J, Chewning J, Verneris MR, Epstein S, Burroughs L, Perez-Albuerne ED, Pulsipher MA, Delaney C) Biol Blood Marrow Transplant 2018 Aug;24(8):1651-1656 PMID: 29753157 PMCID: PMC6108922 SCOPUS ID: 2-s2.0-85047460893 05/13/2018       15 Citations
  • Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art. (Connelly JA, Marsh R, Parikh S, Talano JA) J Pediatric Infect Dis Soc 2018 May 09;7(suppl_1):S31-S39 PMID: 29746680 PMCID: PMC5946867 SCOPUS ID: 2-s2.0-85048642626 05/11/2018       38 Citations
  • Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation. (Duncan CN, Brazauskas R, Huang J, Shaw BE, Majhail NS, Savani BN, Flowers MED, Battiwalla M, Beebe K, Dietz AC, Dvorak CC, Giller R, Jacobsohn DA, Kletzel M, Martin PL, Nemecek ER, Nuechterlein B, Talano JA, Pulsipher MA, Baker KS) Bone Marrow Transplant 2018 Oct;53(10):1278-1287 PMID: 29581480 PMCID: PMC6158112 SCOPUS ID: 2-s2.0-85044469262 03/28/2018       26 Citations
  • Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis. (Broglie L, Pommert L, Rao S, Thakar M, Phelan R, Margolis D, Talano J) Blood Adv 2017 Aug 22;1(19):1533-1536 PMID: 29296794 PMCID: PMC5728466 SCOPUS ID: 2-s2.0-85040141428 01/04/2018       104 Citations
  • Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders. (Burroughs LM, Shimamura A, Talano JA, Domm JA, Baker KK, Delaney C, Frangoul H, Margolis DA, Baker KS, Nemecek ER, Geddis AE, Sandmaier BM, Deeg HJ, Storb R, Woolfrey AE) Biol Blood Marrow Transplant 2017 Oct;23(10):1669-1677 PMID: 28602958 PMCID: PMC5605451 SCOPUS ID: 2-s2.0-85025429864 06/13/2017       42 Citations
  • Usual and Unusual Manifestations of Familial Hemophagocytic Lymphohistiocytosis and Langerhans Cell Histiocytosis. (Erker C, Harker-Murray P, Talano JA) Pediatr Clin North Am 2017 Feb;64(1):91-109 PMID: 27894453 SCOPUS ID: 2-s2.0-84998773661 11/30/2016       10 Citations
  • Salvage therapy for refractory hemophagocytic lymphohistiocytosis: A review of the published experience. (Marsh RA, Jordan MB, Talano JA, Nichols KE, Kumar A, Naqvi A, Vaiselbuh SR, Histiocyte Society Salvage Therapy Working Group) Pediatr Blood Cancer 2017 Apr;64(4) PMID: 27786410 SCOPUS ID: 2-s2.0-84999791337 10/28/2016       40 Citations
  • Successful treatment of recurrent CNS disease post-bone marrow transplant in children with familial hemophagocytic lymphohistiocytosis. (Bock AM, LeVeque M, Camitta B, Talano JA) Pediatr Blood Cancer 2016 Dec;63(12):2154-2158 PMID: 27565627 SCOPUS ID: 2-s2.0-84983551835 10/21/2016       3 Citations
  • Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience. (Morillo-Gutierrez B, Beier R, Rao K, Burroughs L, Schulz A, Ewins AM, Gibson B, Sedlacek P, Krol L, Strahm B, Zaidman I, Kalwak K, Talano JA, Woolfrey A, Fraser C, Meyts I, Müller I, Wachowiak J, Bernardo ME, Veys P, Sykora KW, Gennery AR, Slatter M) Blood 2016 Jul 21;128(3):440-8 PMID: 27216217 PMCID: PMC4957165 SCOPUS ID: 2-s2.0-84979529945 05/25/2016       110 Citations
  • Curative treatment for severe sickle cell disease: allogeneic transplantation. (Oshrine B, Talano JA) Clin Adv Hematol Oncol 2015 Apr;13(4):249-56 PMID: 26352583 SCOPUS ID: 2-s2.0-84926621177 09/10/2015       3 Citations
  • Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant Research. (Burke MJ, Verneris MR, Le Rademacher J, He W, Abdel-Azim H, Abraham AA, Auletta JJ, Ayas M, Brown VI, Cairo MS, Chan KW, Diaz Perez MA, Dvorak CC, Egeler RM, Eldjerou L, Frangoul H, Guilcher GMT, Hayashi RJ, Ibrahim A, Kasow KA, Leung WH, Olsson RF, Pulsipher MA, Shah N, Shah NN, Thiel E, Talano JA, Kitko CL) Biol Blood Marrow Transplant 2015 Dec;21(12):2154-2159 PMID: 26327632 PMCID: PMC4654112 SCOPUS ID: 2-s2.0-84947443750 09/04/2015       22 Citations
  • Smoothing the crescent curve: sickle cell disease. (Talano JA, Cairo MS) Hematology Am Soc Hematol Educ Program 2014 Dec 05;2014(1):468-74 PMID: 25696896 SCOPUS ID: 2-s2.0-84937575445 02/20/2015       6 Citations
  • Hematopoietic stem cell transplantation for sickle cell disease: state of the science. (Talano JA, Cairo MS) Eur J Haematol 2015 May;94(5):391-9 PMID: 25200500 SCOPUS ID: 2-s2.0-84926509714 09/10/2014       27 Citations
  • Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial. (Burroughs LM, Nemecek ER, Torgerson TR, Storer BE, Talano JA, Domm J, Giller RH, Shimamura A, Delaney C, Skoda-Smith S, Thakar MS, Baker KS, Rawlings DJ, Englund JA, Flowers ME, Deeg HJ, Storb R, Woolfrey AE) Biol Blood Marrow Transplant 2014 Dec;20(12):1996-2003 PMID: 25196857 PMCID: PMC4324724 SCOPUS ID: 2-s2.0-84912123151 09/10/2014       50 Citations
  • Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma. (Satwani P, Jin Z, Martin PL, Bhatia M, Garvin JH, George D, Chaudhury S, Talano J, Morris E, Harrison L, Sosna J, Peterson M, Militano O, Foley S, Kurtzberg J, Cairo MS) Leukemia 2015 Feb;29(2):448-55 PMID: 24938649 SCOPUS ID: 2-s2.0-84922470679 06/19/2014       34 Citations
  • New frontiers in pediatric Allo-SCT. (Talano JM, Pulsipher MA, Symons HJ, Militano O, Shereck EB, Giller RH, Hancock L, Morris E, Cairo MS) Bone Marrow Transplant 2014 Sep;49(9):1139-45 PMID: 24820213 PMCID: PMC4439009 SCOPUS ID: 2-s2.0-85027926076 05/14/2014       5 Citations
  • Indications for transplantation in childhood acute leukemia and the impact of minimal residual disease on relapse: A review (Thakar MS, Talano JAM, Tower RL, Kelly ME, Burke MJ) Clinical Practice January 2014;11(1):79-90 SCOPUS ID: 2-s2.0-84896522397 01/01/2014       1 Citation
  • Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients. (Kurtzberg J, Prockop S, Teira P, Bittencourt H, Lewis V, Chan KW, Horn B, Yu L, Talano JA, Nemecek E, Mills CR, Chaudhury S) Biol Blood Marrow Transplant 2014 Feb;20(2):229-35 PMID: 24216185 SCOPUS ID: 2-s2.0-84893106561 11/13/2013       181 Citations
  • The use of novel Therakos™ Cellex® for extracorporeal photopheresis in treatment of graft-versus-host disease in paediatric patients. (Rangarajan HG, Punzalan RC, Camitta BM, Talano JA) Br J Haematol 2013 Nov;163(3):357-64 PMID: 23961954 SCOPUS ID: 2-s2.0-84885418957 08/22/2013       19 Citations
  • Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens. (Chellapandian D, Das R, Zelley K, Wiener SJ, Zhao H, Teachey DT, Nichols KE, EBV-HLH Rituximab Study Group) Br J Haematol 2013 Aug;162(3):376-82 PMID: 23692048 PMCID: PMC3776423 SCOPUS ID: 2-s2.0-84880319443 05/23/2013       173 Citations
  • Clinical outcomes of children receiving intensive cardiopulmonary support during hematopoietic stem cell transplant. (Duncan CN, Lehmann LE, Cheifetz IM, Greathouse K, Haight AE, Hall MW, Herschberger A, Hill KS, Moffet JR, Morrison RR, Norris AL, Petrovic A, Spear DA, Steiner ME, Talano JA, Tamburro RF, Wagner J, McArthur J, Pediatric Acute Lung Injury and Sepsis (PALISI) Network) Pediatr Crit Care Med 2013 Mar;14(3):261-7 PMID: 23392372 SCOPUS ID: 2-s2.0-84874940076 02/09/2013       55 Citations
  • Monitoring and prevention of relapse after allogeneic hematopoietic cell transplantation for myeloid malignancies. (Bacher U, Talano JA, Bishop MR) Biol Blood Marrow Transplant 2012 Jan;18(1 Suppl):S62-73 PMID: 22226115 SCOPUS ID: 2-s2.0-84855410095 01/18/2012       20 Citations
  • Allogeneic cellular and autologous stem cell therapy for sickle cell disease: 'whom, when and how'. (Freed J, Talano J, Small T, Ricci A, Cairo MS) Bone Marrow Transplant 2012 Dec;47(12):1489-98 PMID: 22179556 SCOPUS ID: 2-s2.0-84870804411 12/20/2011       18 Citations
  • Critical Illness Involving Children Undergoing Hematopoietic Progenitor Cell Transplantation (McArthur JA, Bambach B, Duncan C, Talano JA, Tamburro RT) Pediatric Critical Care 2011:1177-1190 SCOPUS ID: 2-s2.0-84884434163 12/01/2011       1 Citation
  • Treatment of recurrent CNS disease post-bone marrow transplant in familial HLH. (Rangarajan HG, Grochowski D, Mulberry MF, Gheorghe G, Camitta BM, Talano JA) Pediatr Blood Cancer 2012 Jul 15;59(1):189-90 PMID: 21755594 SCOPUS ID: 2-s2.0-84861218979 07/15/2011       2 Citations
  • Association of Crohn's disease, thiopurines, and primary epstein-barr virus infection with hemophagocytic lymphohistiocytosis. (Biank VF, Sheth MK, Talano J, Margolis D, Simpson P, Kugathasan S, Stephens M) J Pediatr 2011 Nov;159(5):808-12 PMID: 21722918 PMCID: PMC3191286 SCOPUS ID: 2-s2.0-80054753242 07/05/2011       64 Citations
  • Critical Illness Involving Children Undergoing Hematopoietic Progenitor Cell Transplantation (McArthur JA, Bambach B, Duncan C, Talano JA, Tamburro RT) Pediatric Critical Care: Expert Consult Premium Edition 14 April 2011:1177-1190 SCOPUS ID: 2-s2.0-85136761775 04/14/2011    
  • Delayed hemolytic transfusion reaction in children with sickle cell disease. (de Montalembert M, Dumont MD, Heilbronner C, Brousse V, Charrara O, Pellegrino B, Piguet C, Soussan V, Noizat-Pirenne F) Haematologica 2011 Jun;96(6):801-7 PMID: 21330322 PMCID: PMC3105640 SCOPUS ID: 2-s2.0-79958072849 02/19/2011       80 Citations
  • Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study. (Prasad VK, Lucas KG, Kleiner GI, Talano JA, Jacobsohn D, Broadwater G, Monroy R, Kurtzberg J) Biol Blood Marrow Transplant 2011 Apr;17(4):534-41 PMID: 20457269 SCOPUS ID: 2-s2.0-79952624644 05/12/2010       251 Citations
  • Focal nodular hyperplasia in pediatric allogeneic hematopoietic cell transplant: case series. (Anderson L, Gregg D, Margolis D, Casper J, Talano J) Bone Marrow Transplant 2010 Aug;45(8):1357-9 PMID: 20140023 SCOPUS ID: 2-s2.0-77955561931 02/09/2010       20 Citations
  • Antiviral responses following L-leucyl-L-leucine methyl esther (LLME)-treated lymphocyte infusions: graft-versus-infection without graft-versus-host disease. (Filicko-O'Hara J, Grosso D, Flomenberg PR, Friedman TM, Brunner J, Drobyski W, Ferber A, Kakhniashvili I, Keever-Taylor C, Mookerjee B, Talano JA, Wagner JI, Korngold R, Flomenberg N) Biol Blood Marrow Transplant 2009 Dec;15(12):1609-19 PMID: 19744572 PMCID: PMC2783272 SCOPUS ID: 2-s2.0-70350459268 09/12/2009       7 Citations
  • Hematopoietic Cell Transplantation for Childhood Acute Myeloid Leukemia (Talano JAM, Casper JT, Margolis DA) Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation, Fourth Edition 5 March 2009:775-790 SCOPUS ID: 2-s2.0-84890702087 03/05/2009    
  • Severe hypercholesterolemia mediated by lipoprotein X in a pediatric patient with chronic graft-versus-host disease of the liver. (Zidan H, Lo S, Wiebe D, Talano J, Alemzadeh R) Pediatr Blood Cancer 2008 Jun;50(6):1280-1 PMID: 18286546 SCOPUS ID: 2-s2.0-42349086297 02/21/2008       17 Citations
  • Voriconazole-induced blistering in the setting of graft versus host disease: A report of 2 patients. (Conlon JD, Dauenhauer M, Tonkovic-Capin V, Talano J, Margolis D, Drolet BA, Fairley JA) J Am Acad Dermatol 2008 Mar;58(3):484-7 PMID: 18280346 SCOPUS ID: 2-s2.0-38949186469 02/19/2008       11 Citations
  • Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled trial. (Cohen EP, Irving AA, Drobyski WR, Klein JP, Passweg J, Talano JA, Juckett MB, Moulder JE) Int J Radiat Oncol Biol Phys 2008 Apr 01;70(5):1546-51 PMID: 18029109 PMCID: PMC2386758 SCOPUS ID: 2-s2.0-40949138809 11/22/2007       73 Citations
  • Recent molecular and cellular advances in pediatric bone marrow transplantation. (Talano JA, Margolis DA) Pediatr Clin North Am 2006 Aug;53(4):685-98 PMID: 16872999 SCOPUS ID: 2-s2.0-33746253782 07/29/2006       2 Citations
  • Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL. (Talano JM, Casper JT, Camitta BM, Keever-Taylor CA, Murray KJ, Eapen M, Pierce KL, Margolis DA) Bone Marrow Transplant 2006 Jan;37(2):135-41 PMID: 16273115 SCOPUS ID: 2-s2.0-30944438521 11/08/2005       16 Citations
  • Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. (Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP) Pediatrics 2003 Jun;111(6 Pt 1):e661-5 PMID: 12777582 SCOPUS ID: 2-s2.0-17344391561 06/05/2003       161 Citations
  • Long-term follow-up of children with fever of unknown origin. (Talano JA, Katz BZ) Clin Pediatr (Phila) 2000 Dec;39(12):715-7 PMID: 11156069 SCOPUS ID: 2-s2.0-0034541851 01/13/2001       20 Citations
  • Inhibition of human type IV collagenase by a highly conserved peptide sequence derived from its prosegment. (Stetler-Stevenson WG, Talano JA, Gallagher ME, Krutzsch HC, Liotta LA) Am J Med Sci 1991 Sep;302(3):163-70 PMID: 1656751 SCOPUS ID: 2-s2.0-0026043472 09/01/1991       36 Citations
    • Last update: 05/13/2024